StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a research note published on Monday. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 0.5 % BTX opened at $2.05 on Monday. The firm’s fifty day simple moving average is $2.88. Brooklyn ImmunoTherapeutics has a 52-week low […]
StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a research note issued to investors on Monday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 0.5 % Brooklyn ImmunoTherapeutics stock opened at $1.99 on Monday. The company has a market capitalization of $117.06 million, a […]
StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a report released on Sunday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 3.9 % Shares of NYSE:BTX opened at $2.23 on Friday. The company’s 50 day moving average price is $3.04. The stock has a market […]
Research analysts at StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a research note issued on Sunday. The firm set a “hold” rating on the stock. Brooklyn ImmunoTherapeutics Price Performance BTX stock opened at $2.32 on Friday. Brooklyn ImmunoTherapeutics has a fifty-two week low of $0.17 and a fifty-two week […]
StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a report released on Saturday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 2.9 % BTX stock opened at $2.48 on Friday. The business’s 50-day simple moving average is $3.18. The company has a market capitalization of […]